TFAP2E-DKK4 and Chemoresistance in Colorectal Cancer

N Engl J Med. 2012 Jan 5;366(1):44-53, MP Ebert, M Tanzer, B Balluff, RM Schmid, et al

TAKE-HOME MESSAGE

Abstract

SUMMARY

OncologySTAT Editorial Team

The molecular mechanisms underlying chemotherapy resistance in patients with colorectal cancer are not well known, but may be related to epigenetic alterations of the gene encoding transcription factor AP-2 epsilon (TFAP2E). The gene encoding dickkopf homolog 4 protein (DKK4) is a possible downstream target of TFAP2E and has been implicated in fluorouracil resistance in patients with colorectal cancer. The current study evaluated the role of TFAP2E in predicting response to chemotherapy in patients...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

About Our Journal Scans

View a list of journals that the OncologySTAT editorial team scans every week in order to bring you the most practice-relevant original research and review articles.

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration